학술논문

A multicenter study of epirubicin-docetaxel (ET) as primary chemotherapy for patients with inflammatory breast cancer (IBC)
Document Type
Journal
Source
BREAST; MAR 2007, 16 pS48-pS48, 1p. Supplement: 1
Subject
Language
English
ISSN
09609776